{"schema_version":"secwatch.filing_event.v1","accession":"0001730463-23-000106","form_type":"8-K","ticker":"AUTL","cik":"0001730463","company_name":"Autolus Therapeutics plc","filed_at":"2023-11-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:30.216587+00:00","generated_at":"2026-06-08T07:07:37.285972+00:00","sec_items":["7.01"],"event_type":"regulatory","sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Autolus voluntarily elects U.S. domestic issuer reporting, no change to Q3 2023 financials","bullets":["Autolus will file periodic reports on Forms 10-K, 10-Q, and 8-K instead of foreign private issuer forms.","No financial or disclosure changes from the Form 6-K filed on November 2, 2023 for the quarter ended September 30, 2023.","Company retains foreign private issuer status, exempt from U.S. proxy rules, Regulation FD, and Section 16.","Effective immediately; first U.S. domestic issuer report to be filed later today (Q3 2023 Form 10-Q)."],"urls":{"canonical":"https://secwatch.observer/filing/0001730463-23-000106","json":"https://secwatch.observer/filing/0001730463-23-000106.json","markdown":"https://secwatch.observer/filing/0001730463-23-000106.md","text":"https://secwatch.observer/filing/0001730463-23-000106.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1730463/000173046323000106/0001730463-23-000106-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1730463/000173046323000106/autl-20231109.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-08T07:07:37.285972+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}